• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Vanda Pharmaceuticals Inc - Articles and news items

Phase III results for Vanda’s Hetlioz published in The Lancet

Industry news / 5 August 2015 / Victoria White

Pivotal trial results from Phase III studies of Vanda Pharmaceuticals’ Hetlioz® (tasimelteon) have been published in The Lancet…


Webinar: NIR Spectroscopy for Assessing Blend Uniformity in the Pharmaceutical IndustryLEARN MORE
+ +